Exhibit 23.2

             Consent of Deloitte & Touche, LLP, Independent Auditors





INDEPENDENT AUDITORS' CONSENT

We consent to the incorporation by reference in this Registration Statement of
Ligand Pharmaceuticals Incorporated on Form S-8 of our report dated February 25,
2003 (which report expresses an unqualified opinion and includes an explanatory
paragraph referring to a change in accounting principle), appearing in the
Annual Report on Form 10-K of Ligand Pharmaceuticals Incorporated for the year
ended December 31, 2002.


/S/DELOITTE & TOUCHE LLP


San Diego, California
June 23, 2003